Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Jan;5(1):57-67.
doi: 10.1007/BF00365534.

Optimization of serum-free fermentation processes for antibody production

Affiliations
Free article

Optimization of serum-free fermentation processes for antibody production

H Büntemeyer et al. Cytotechnology. 1991 Jan.
Free article

Abstract

Serum free fermentation procedures of cell cultures have got a wide application in production of biochemicals. But, cells cultured in serum free media in general are more sensitive to changes in culture condition, especially to nutrient limitation. There are no substances from serum which can support the cells when conditions are changing. In this study special attention is directed to amino acid utilization of mouse hybridoma in batch, chemostat and perfusion fermentations. Detailed data are presented which show the considerable difference of amino acid consumption rates in different fermentation modes. Already, in batch mode there are differences of the two investigated mouse hybridoma cell lines, although they are derived from the same myeloma line. In chemostat running at a dilution rate representing maximal growth rate most of the consumption rates are significant higher than in batch. On the other hand, in perfusion mode the rates are lower than in batch. This indicates clearly the different conditions of the fermentation modes. Therefore, it is necessary to develop serum free processes under the desired production conditions. An accurate analysis of the process is strongly recommended.

PubMed Disclaimer

References

    1. Biotechnol Bioeng. 1988 Feb 5;31(2):168-72 - PubMed
    1. Cytotechnology. 1988 Nov;1(4):319-29 - PubMed
    1. Science. 1959 Aug 21;130(3373):432-7 - PubMed
    1. Cytotechnology. 1989 May;2(2):119-29 - PubMed
    1. Cytotechnology. 1988 Feb;1(2):145-50 - PubMed

LinkOut - more resources